XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Xtant Medical Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.29+0.00 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $40.82M
- P/E (TTM)
- –
- Dividend yield
- –
Xtant Medical Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $23.03M | $20.88M | $27.71M | $27.77M | $30.44M | $29.28M | $30.01M | $27.94M | $29.94M | $27.87M | – | – | 100.0% | -24.3% |
| Orthobiologics [Member] | $17.36M | $15.61M | $18.30M | $17.15M | $19.37M | $18.07M | $18.30M | $16.58M | $16.13M | $15.42M | $15.07M | $15.67M | 75.4% | -10.4% |
| Spinal Implant [Member] | $5.67M | $5.28M | $9.41M | $10.62M | $11.07M | $11.21M | $11.72M | $11.36M | $13.82M | $12.46M | $13.03M | $9.35M | 24.6% | -48.8% |
| Bill and Hold Transactions [Member] | $100.00K | $100.00K | – | $200.00K | $0 | $400.00K | – | – | – | – | – | – | 0.4% | – |
| License Revenue [Member] | – | – | $4.65M | $5.48M | $4.98M | $3.62M | – | – | – | – | – | – | – | – |
| License [Member] | – | – | $4.65M | $5.48M | $4.98M | $3.62M | – | – | – | – | – | – | – | – |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $22.46M | $20.71M | $29.89M | $30.31M | $32.13M | $30.12M | $28.77M | $25.34M | $26.28M | $25.13M | $24.93M | $23.43M | 97.5% | -30.1% |
| Non-US [Member] | $569.00K | $177.00K | $2.47M | $2.94M | $3.28M | $2.79M | $2.75M | $2.60M | – | – | – | – | 2.5% | -82.6% |
| Rest Of World [Member] | – | – | – | – | $3.28M | $2.79M | $2.75M | $2.60M | $3.67M | $2.74M | $3.18M | $1.59M | – | – |
From the segment and revenue-disaggregation notes of Xtant Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.